In summary, these findings provide some clinical and functional evidence that the C.793-1G>A variant of MSH2 gene can contribute to LS and can be further studied as a potential target for the diagnosis and treatment of colon cancer. The gene discussed is MSH2; the disease is Leigh syndrome.